CYCLOPHOSPHAMIDE TABLETS IP 50 mg — CYCLOPAS

Product Overview — CYCLOPHOSPHAMIDE TABLETS IP 50 mg (CYCLOPAS)

CYCLOPAS (Cyclophosphamide Tablets IP 50 mg) is a potent prescription chemotherapy medication and immunosuppressant used in the treatment of various cancers and severe autoimmune disorders.

Cyclophosphamide works by alkylating DNA, which helps inhibit cancer-cell growth. Its immunosuppressive action also helps manage serious immune-mediated conditions such as lupus nephritis.

  • Product/Composition: Cyclophosphamide 50 mg
  • Pharmaceutical Form: Tablets
  • Strength/Pack: 50 mg
  • Medicine Category: Prescription chemotherapy medication and immunosuppressant
CYCLOPHOSPHAMIDE TABLETS IP 50 mg — CYCLOPAS product pack

Therapeutic Indications

  • Used as part of combination chemotherapy regimens.
  • Frequently included in combination protocols for breast cancer.
  • Used for adenocarcinoma of the ovary.
  • May be used for retinoblastoma, neuroblastoma, mycosis fungoides, and sarcoma.
  • Chronic lymphocytic leukemia.
  • Hodgkin's lymphoma.
  • Non-Hodgkin's lymphoma.
  • Multiple myeloma.
  • Severe lupus nephritis associated with systemic lupus erythematosus.
  • Severe, life-threatening vasculitis.
  • Progressive rheumatoid arthritis and other myopathies.
  • Minimal change nephrotic syndrome, especially in pediatric cases.
  • Used in high doses, orally or intravenously, to suppress the immune system.
  • May be used to help prevent transplant rejection.
  • May be used in the management or prevention of graft-versus-host disease.

Mechanism & Clinical Use of CYCLOPAS

CYCLOPAS (Cyclophosphamide Tablets IP 50 mg) is an alkylating medicine. It acts on DNA to inhibit the growth and multiplication of cancer cells.

Its immune-suppressing effect also makes it useful in selected severe autoimmune and immune-mediated diseases where suppression of abnormal immune activity is required.

Important Information — CYCLOPHOSPHAMIDE TABLETS IP 50 mg

CYCLOPAS contains cyclophosphamide 50 mg and is classified as a potent prescription chemotherapy medication and immunosuppressant.

Cyclophosphamide is commonly used as part of combination chemotherapy regimens for breast cancer, blood and lymphatic cancers, ovarian cancer, and selected other malignancies.

Its immunosuppressive action may be used in severe lupus nephritis, life-threatening vasculitis, progressive rheumatoid arthritis, other myopathies, minimal change nephrotic syndrome, and selected transplantation settings.

This medicine should be taken only when prescribed and monitored by a qualified healthcare professional. Patients should not start, stop, or change the dose without medical advice.

Product Details — CYCLOPAS

Brand Name: CYCLOPAS

Generic Name: Cyclophosphamide

Composition: Cyclophosphamide 50 mg

Pharmaceutical Form: Tablets

Strength/Pack: 50 mg

Therapeutic Category: Chemotherapy medication and immunosuppressant

Usage: For use only as directed by a registered medical practitioner.